Meeting Coverage

DDW Expert Roundtable

Expert Roundtable from Digestive Disease Week

Risankizumab Safe, Effective in Moderate to Severe Crohn's Disease

Our expert panel discusses the positive data from the phase III ADVANCE and MOTIVATE studies

image

Latest DDW Expert Roundtable Meetings

'How Long Do I Need to Stay on Crohn's Therapy?'

Our panel discusses a trial on infliximab discontinuation in patients in remission

June 28, 2021
Biologic Therapies for Crohn's Go Head-to-Head at DDW

SEAVUE compares ustekinumab with adalimumab in patients with moderate to severe disease

June 21, 2021
Do COVID-19 Vaccines Protect IBD Patients?

CLARITY IBD findings weren't clear for IBD patients on infliximab, these experts noted

June 14, 2021